Breast Cancer Perspective

• Key Strategies for Managing Breast Cancer Brain Metastases Breast cancer specialist Kevin M. Kalinsky, MD, discusses the interplay of tumor characteristics and treatment options.
  Medscape Oncology, June 17, 2021
• ASCO 2021 For Residual TNBC Post-Chemo, Capecitabine Should Be Offered   For high-risk patients with triple-negative breast cancer who have residual disease following neoadjuvant therapy, Dr Kathy Miller says we must accept capecitabine as the standard of care.
  Medscape Oncology, June 15, 2021
• ASCO 2021 Olaparib Beneficial for BRCA-Mutated HER2-Negative Breast Cancer   Dr Kathy Miller shares the 'biggest news in the breast cancer world' from ASCO, with presented data showing the benefit of olaparib in patients with high-risk, BRCA-mutated HER2-negative disease.
  Medscape Oncology, June 11, 2021
• Why Do We Treat Early Breast Cancer Like It’s the Dark Ages? Reconstruction vs Conservation is the age-old question when it comes to breast care.
  Medscape Blogs, June 07, 2021
• ASCO 2021 ASCO 2021: Breast Cancer Sessions Not to Miss   Dr Kathy Miller discusses anticipated highlights of ASCO 2021.
  Medscape Oncology, June 02, 2021
• Evolving Strategies in Sequencing for HER2+ MBC Therapy Therapies targeting HER2+ MBC are evolving rapidly. Several recent FDA approvals offer experts an array of new options and prompt a reevaluation of treatments and sequencing strategies.
  Medscape Oncology, May 24, 2021
• Can You Explain 'Relative Risk' in COVID-19? Our risk-communication toolkit is often too generic for individual decision-making.
  Medscape Internal Medicine, May 21, 2021
• 'Living at Work': Work-Life Balance in a Pandemic A physician reaches out to colleagues for advice on rebalancing his professional and personal obligations.
  Medscape Oncology, May 10, 2021
• The Power of Independent Data Monitoring Committees Is Diminishing   Dr Kathy Miller sees the power of IDMCs eroding, and warns that this will lead to a loss of confidence in the safety and reliability of new treatments.
  Medscape Oncology, May 05, 2021
• ANA Testing in a Postpartum Patient at Risk for Dermatomyositis The progression of a 32-year-old woman's dermatomyositis -- a rash that resolved during pregnancy, only to recur postpartum, along with fatigue and weakness.
  HSS Grand Rounds Complex Cases, May 04, 2021
• Single-Cell Sequencing Upends Breast Cancer Assumptions   This study turns previous assumptions about the genesis of breast cancers on its head, says Dr Kathy Miller.
  Medscape Oncology, April 28, 2021
• How COVID-19 Could Change Healthcare   WebMD's Chief Medical Officer, John Whyte, MD, speaks with Lloyd B. Minor, MD, Dean, Stanford University School of Medicine, about the influence of COVID-19 and technology on the future of health care.
  WebMD, April 09, 2021
• Improve Doctor-Patient Relationships With This One Question After personal tragedy struck, Dr Doug Lake found himself more closely considering his patients' experiences, completely changing how he interacted with them.
  Medscape, April 05, 2021
• Treating Metastatic TNBC: Where Are We Now? New antibody-drug conjugates are a step in the right direction, but the key to developing effective therapies hinges on identifying the best molecular targets.
  Medscape Oncology, March 29, 2021
• Defining Optimal Therapy in High-Risk Early Breast Cancer: Gray Areas   Stanford oncologists discuss strategies to select optimal therapies to prevent recurrence in high-risk breast cancers and minimize toxicities of therapy.
  Medscape TV, March 26, 2021
• Painful Armpit Swelling After COVID Vaccine: Next Steps? This clinical case, with images, highlights an effective collaboration between a gynecologist and a radiologist.
  Medscape Ob/Gyn, March 23, 2021
• Cancer News to 'Shout From the Rooftops'   Between 1988 and 2021, 5 million cancer deaths have been avoided because of improvements in prevention, early diagnosis, and treatment, according to a new study.
  Medscape Oncology, March 16, 2021
• Lifestyle Alone Cannot Shield Us From Cancer   Dr Mark Lewis laments the tendency to look for preventable reasons why people get cancer.
  Medscape Oncology, March 15, 2021
• Treatment of Metastatic Triple-Negative Breast Cancer: Sacituzumab Govitecan   Dr Linda Vahdat provides an update on the ASCENT trial and recent progress for the antibody drug conjugate sacituzumab govitecan in the treatment of metastatic triple-negative breast cancer.
  March 05, 2021
• Battle of the Sexes: Who Gives Better Medical Care? Does physician gender affect quality of care? Dr Arghavan Salles takes a look at the evidence.
  Medscape Diabetes & Endocrinology, March 01, 2021